Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.1K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The cytokine Prokineticin-1 in preterm labor with and without intra-amniotic inflammation.

Journal of perinatal medicine·2026
Same author

A comprehensive review of emerging frontiers in starch biomacromolecules for targeted drug delivery, precision nutrition, and sustainability.

Carbohydrate research·2026
Same author

Sonographic measurement of placental volume: a comparative analysis of two-dimensional and three-dimensional sonographic techniques.

Journal of perinatal medicine·2026
Same author

New biomarkers for the detection of fetal death derived from large-scale proteomic analysis of maternal plasma.

American journal of obstetrics and gynecology·2026
Same author

SPG4 and Dementia: Expanding the Clinical Spectrum.

Annals of clinical and translational neurology·2026
Same author

A subclinical cytokine storm is present before the clinical diagnosis of amniotic fluid embolism: implications for the prediction and prevention of maternal death.

American journal of obstetrics and gynecology·2026

Related Experiment Video

Updated: Oct 3, 2025

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia
07:32

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia

Published on: February 9, 2020

7.9K

Hereditary Spastic Paraplegia: An Update.

Arun Meyyazhagan1, Antonio Orlacchio1,2

  • 1Dipartimento di Medicina e Chirurgia, Università di Perugia, 06132 Perugia, Italy.

International Journal of Molecular Sciences
|February 15, 2022
PubMed
Summary

Hereditary spastic paraplegia (HSP) is a rare neurodegenerative disorder affecting lower limb spasticity. This review details HSP

Keywords:
hereditary spastic paraplegianeurodegenerative diseaseneurogenetics

More Related Videos

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
10:49

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Published on: September 18, 2011

20.8K
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

19.7K

Related Experiment Videos

Last Updated: Oct 3, 2025

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia
07:32

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia

Published on: February 9, 2020

7.9K
Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
10:49

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Published on: September 18, 2011

20.8K
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

19.7K

Area of Science:

  • Neuroscience
  • Genetics
  • Rare Diseases

Background:

  • Hereditary spastic paraplegia (HSP) is a rare neurodegenerative disorder characterized by progressive spasticity in the lower extremities.
  • Pathophysiology involves axonal degeneration in the corticospinal tracts of the spinal cord.
  • Current symptomatic treatments offer limited satisfaction.

Purpose of the Study:

  • To review and assimilate current data on Hereditary spastic paraplegia.
  • To identify chromosomes and gene mutations implicated in HSP pathophysiology.
  • To summarize available treatments, diagnostic techniques, and future pharmacogenomic perspectives.

Main Methods:

  • Comprehensive literature review of existing data on HSP.
  • Analysis of genetic factors, including chromosomal locations and gene mutations.
  • Compilation of information on therapeutic interventions and diagnostic approaches.

Main Results:

  • Identified specific chromosomes and gene mutations associated with HSP.
  • Detailed various treatment modalities, including medications, physical therapy, and surgery.
  • Highlighted diagnostic techniques and emerging pharmacogenomic research.

Conclusions:

  • HSP is a complex genetic disorder requiring further research into its pathophysiology.
  • A multi-faceted approach involving genetic understanding, diagnostics, and varied treatments is crucial for managing HSP.
  • Pharmacogenomics holds promise for future personalized therapeutic strategies in HSP.